UroGen Pharma URGN Liability For Uncertain Tax Positions Noncurrent
Liability For Uncertain Tax Positions Noncurrent at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForUncertainTaxPositionsNoncurrent.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's liability for uncertain tax positions noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's liability for uncertain tax positions noncurrent?
- UroGen Pharma (URGN) reported liability for uncertain tax positions noncurrent of $3.9M in Q1 2026.
- How has UroGen Pharma's liability for uncertain tax positions noncurrent changed year-over-year?
- UroGen Pharma's liability for uncertain tax positions noncurrent increased by 3.0% year-over-year, from $3.79M to $3.9M.
- What is the long-term trend for UroGen Pharma's liability for uncertain tax positions noncurrent?
- Over 5 years (2020 to 2025), UroGen Pharma's liability for uncertain tax positions noncurrent has grown at a 7.5% compound annual growth rate (CAGR), from $2.72M to $3.9M.